Catalytic Asymmetric Synthesis Of P-Chiral Phosphoramidates
Tech ID: 34876 / UC Case 2026-716-0
Brief Description
A highly selective method for producing P-chiral phosphorus(V) compounds, eliminating complex purification steps while enabling the development of pharmaceuticals, agrochemicals, and other bioactive molecules.
Full Description
A novel yttrium-catalyzed method enables efficient and stereoselective synthesis of P-chiral phosphorus(V) compounds, providing versatile building blocks for the development of pharmaceuticals, agrochemicals, ProTides, and other therapeutically relevant molecules.
Suggested uses
- Pharmaceutical synthesis targeting antiviral and therapeutic nucleoside analogues
- Agrochemical development involving P-stereogenic phosphoramidates
- Total synthesis of complex bioactive molecules such as phosmidosine
- Medicinal chemistry for designing novel P-(V) therapeutic scaffolds
- Catalyst and reagent development for asymmetric organophosphorus chemistry
Advantages
- High enantioselectivity with chiral yttrium catalyst
- One-pot process combining nucleophilic substitutions
- Eliminates need for diastereomer separation
- Compatible with medicinally relevant nucleosides
- Provides trifunctional P-chiral building blocks for diverse application
Patent Status
Patent Pending